Risk-sharing in the Pharmaceutical Industry The Case of Out-licensing /

• Κύριος συγγραφέας: Reepmeyer, Gerrit (Συγγραφέας)
• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Heidelberg : Physica-Verlag HD, 2006.
• Σειρά: Contributions to Management Science,
• Θέματα: Business.; Leadership.; Management.; Industrial management.; Economics.; Management science.; Business and Management.; Business Strategy/Leadership.; Economics, general.; Innovation/Technology Management.

The costs of developing a new drug have reached record levels in the pharmaceutical industry. As any failure of a new drug candidate can lead to significant losses, many pharmaceutical companies are looking for new approaches to reduce their exposure to R&D risks. In this context, the book deals...

Πίνακας περιεχομένων:

• Key Issues in Managing Pharmaceutical Innovation
• Risk-sharing as New Paradigm in Pharma R&D Collaborations
• Case Studies on Risk-sharing in Pharma R&D Collaborations
• Characteristics of Risk-sharing in Pharma R&D Collaborations
• Theoretical Basis for Risk-sharing in Pharma R&D Collaborations
• Managerial Recommendations for Risk-sharing in Pharma R&D Collaborations
• Conclusion.